Ketamine Safety: An Overview
Most risk is procedural, not pharmacological.
This page has been written and edited by the publisher. It has not been reviewed by a licensed clinician.
This is the Safety Center's plain-language entry point: a short orientation to where risk sits before you read the detailed side-effect, interaction, and screening pages beneath it.
Acute session safety
Sub-anesthetic ketamine acutely raises blood pressure and heart rate, produces dissociation, and may cause nausea or dizziness. These are monitored and managed in a clinical setting.
Cumulative safety
Long-term high-dose use is associated with urological complications and cognitive effects. Therapeutic, intermittent dosing in clinical settings has not shown these patterns in published cohorts.
Procedural safety
Most adverse events trace to inadequate screening, missing monitoring, or unsupervised at-home protocols without proper guardrails.
Related reading
Educational content only. Not medical advice. Discuss any treatment decisions with a qualified clinician.
Publisher and editor of Ketalux, based in Chicago, Illinois. Ira is a ketamine therapy patient, not a clinician. This is editorial review, not medical review: Ira is not a licensed clinician and does not provide diagnosis or medical care. Ketalux does not accept compensation from providers in exchange for favorable editorial coverage, evidence ratings, recommendations, patient referrals, or organic provider ranking. Read the full publisher disclosure →
Educational use only. The content on this page is provided for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Ketamine and related therapies carry risks and are appropriate only under qualified medical supervision. Always consult a licensed healthcare professional about your individual situation. Information may change as research evolves.